RhumbLine Advisers’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
54,500
+3,001
| +6% | +$11.4K | ﹤0.01% | 3211 |
|
|
2025
Q1 | $135K | Buy |
51,499
+8,945
| +21% | +$23.5K | ﹤0.01% | 3287 |
|
|
2024
Q4 | $151K | Buy |
42,554
+7,112
| +20% | +$25.2K | ﹤0.01% | 3332 |
|
|
2024
Q3 | $162K | Sell |
35,442
-2,488
| -7% | -$11.3K | ﹤0.01% | 3334 |
|
|
2024
Q2 | $165K | Buy |
37,930
+1,489
| +4% | +$6.48K | ﹤0.01% | 3332 |
|
|
2024
Q1 | $183K | Buy |
36,441
+756
| +2% | +$3.8K | ﹤0.01% | 3224 |
|
|
2023
Q4 | $224K | Buy |
35,685
+767
| +2% | +$4.81K | ﹤0.01% | 3124 |
|
|
2023
Q3 | $249K | Buy |
34,918
+956
| +3% | +$6.81K | ﹤0.01% | 3036 |
|
|
2023
Q2 | $346K | Buy |
+33,962
| New | +$346K | ﹤0.01% | 2923 |
|